The career session offers the great opportunity to gain insight in all the different career options that a graduated PhD student can follow. Like in past years, interesting speakers from various scientific backgrounds will give a short introduction about their own career as well as their current working field and are open for further discussions. In order to cover a broad spectrum, we want to invite speakers from the pharmaceutical industry, scientific research, patent law, institutions such as EMBO or DFG and companies that provide us with technical support. We invite everyone to take part in our session!
|Frank Tegtmeier |
Dr. Tegtmeier has 15 years of experience in research & development acquired at Janssen-Cilag, Germany (a Johnson & Johnson company). After leading several research groups he was head of the preclinical research of Janssen-Cilag. Dr Tegtmeier was responsible for the European coordination of all research activities in the field of CNS-pharmacology and was also in charge of transferring compounds from the preclinical research to the clinical evaluation within a European project management. He was Lecturer at the Heinrich-Heine-University Duesseldorf and taught Pathophysiology of the mammalian brain. He is author of over 100 publications within the fields of cerebral infarction and cerebral pathophysiology.
|Rob Thompson |
Rob Thompson studied mathematics at Bristol University. Afterwards he has worked both in industry and with research scientists helping not-for-profit organisations and groups in the public and private sectors to optimise their interpersonal relationships and group management. By combining his extensive knowledge of people-management with his experience of training and leading groups, Rob Thompson gives workshops to help scientists optimise their interpersonal relationships and group management skills.
|Lisa Polzien |
Patent Lawyer at VOSSIUS & Partner Departments Biology & Biotechnology
Dr. Lisa Polzien was born in Würzburg and studied biology at the University of Greifswald and at the University of Kiel. In 2007, she became a certified biologist in the field of molecular biology, biochemistry and microbiology. Afterwards she started to work on her doctorate at the University Medical Center of Würzburg, the Institute of Microbiology of the University of Würzburg and the Max Planck Institute for Heart and Lung Research in Bad Nauheim. The main focus of her dissertation was the regulation of apoptosis in the treatment of cancer. In this context she analyzed the manipulation of signal transduction pathways for the induction of cell death in tumor cells. In 2011, she joined Vossius & Partner at their Munich office.
|Anne Færch Nielsen |
Editor, The EMBO Journal
Publishing research papers is a cornerstone of working in life sciences, but do you know what actually happens to your manuscript once it is submitted to a scientific journal? In this talk, Anne Nielsen – scientific editor for The EMBO journal – will take you behind the scenes of scientific publishing at EMBO and explain how editors make decisions, find referees and work with authors to improve the revised manuscript. She will also discuss some of the challenges faced by the current publishing landscape, talk about the efforts EMBO is making to prevent errors from entering the literature, and offer advice on manuscript writing and submission. Anne Nielsen obtained her PhD in molecular biology from Aarhus University in Denmark in 2008 and worked as a postdoc in Javier Martinez' lab at IMBA in Vienna for three years before leaving the lab in early 2012 to become a scientific editor for The EMBO Journal in Heidelberg.
|Anne von Thun |
Dr. Anne von Thun completed her PhD at the Beatson Institute for Cancer Research in Glasgow, Scotland. After a three year postdoc she accepted the position of a European Union liaison officer at the University Hospital Würzburg. Dr. von Thun now consults young and experienced scientists on European funding opportunities. She supports researchers in the preparation, negotiation and implementation of EU-funded research projects in Horizon 2020. Her work requires close contact with the European Commission and is placed at the interface of research and administration. Dr. von Thun enjoys being involved in many different but yet exciting research projects with scientists from all over the world.